CLINICAL_TRIALS
trial_result
· 2025-03-05
Clinical Trial Update: Pretomanid in Adults With Hepatic Impairment [Phase 1]
Summary
Phase 1 trial evaluating pretomanid in adults with hepatic impairment was terminated; results have been posted in 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 1 | Status: TERMINATED | Results posted: 2025-03-05